Natera, Inc. (NTRA) Form 10-Q — Aug 6, 2026
Natera's Q2 2026 total revenues rose 37.7% year over year to $752.8 million, with six-month revenue of $1,449.4 million versus $1,048.4 million a year earlier. Gross margin improved to 64.5% from 63.4%. The quarterly net loss narrowed to $67.0 million ($0.47 per share) from $100.9 million ($0.74 per share) a year ago, and the company generated $95.0 million of operating cash flow in the first half of 2026. Natera held $1.09 billion in cash at June 30, 2026 and states existing cash is sufficient for at least 12 months.
Key figures
- Revenue
- 752750000
- Total Debt
- 80291000
- Revenue Yoy
- 37.7% (Q2 YoY); 38.2% (six-month YoY)
- Total Assets
- 2657497000
- Cash Position
- 1091502000
- Shares Outstanding
- 144144170
- Q2 gross margin
- 64.5%
- Six month revenue
- 1449394000
- Accumulated deficit
- 2928082000
- Medicare pct q2 revenue
- 16.5%
- Legal contingency accrual
- 33200000
- Six month stock based comp
- 198204000
- Tests processed six months
- 2056800
- Ravgen infringement verdict
- 57000000
- Six month operating cash flow
- 94964000
- Credit line collateral minimum
- 150000000
- Credit line remaining available
- 20000000
- Prior period revenue true up q2
- 52300000
- Foresight purchase consideration
- 424500000
- Guardant false advertising verdict
- 292500000
- Credit line outstanding incl interest
- 80300000
- Foresight contingent consideration fv
- 120505000
- Foresight contingent consideration max
- 175000000
- Prior period revenue true up six months
- 113300000
Price after filing
Close on the filing date to close N calendar days later (from $275.19). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.